4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
Major government spending bills tend to create both winners and losers. The $1.9 trillion stimulus bill recently passed by Congress and signed into law by President Joe Biden is no exception. In this Motley Fool Live video, recorded on March 10, Fool.com contributors Keith Speights and Brian Orelli discuss four pharma stocks that could be losers as a result of the legislation.
Source Fool.com